TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+25.01%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$251M
AUM Growth
+$251M
(+2.6%)
Cap. Flow
-$22.8M
Cap. Flow
% of AUM
-9.06%
Top 10 Holdings %
Top 10 Hldgs %
83.47%
Holding
27
New
5
Increased
8
Reduced
6
Closed
5
Top Buys
| 1 |
Pacira BioSciences
PCRX
|
$12.2M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$11.3M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$10M |
| 4 |
Medtronic
MDT
|
$6.83M |
| 5 |
Alkermes
ALKS
|
$5.11M |
Top Sells
| 1 |
NUVA
NuVasive, Inc.
NUVA
|
$24.8M |
| 2 |
NovoCure
NVCR
|
$22.4M |
| 3 |
NXTM
NxStage Medical Inc.
NXTM
|
$17.9M |
| 4 |
Service Corp International
SCI
|
$6.22M |
| 5 |
McKesson
MCK
|
$5.52M |
Sector Composition
| 1 | Healthcare | 77% |
| 2 | Industrials | 11.04% |
| 3 | Consumer Discretionary | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1
DELISTED
Veradigm Inc. Common Stock
MDRX
| $33.9M | 13.45% | 3,550,000 +500,000 | +16% | +$4.77M |
|
|
2
Medtronic
MDT
$119B
| $31.9M | 12.66% | 350,000 +75,000 | +27% | +$6.83M |
|
|
SRCL
3
DELISTED
Stericycle Inc
SRCL
| $27.8M | 11.02% | 510,000 +85,000 | +20% | +$4.63M |
|
|
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $25.2M | 9.99% | 725,000 +325,000 | +81% | +$11.3M |
|
5
Lantheus
LNTH
$3.73B
| $23.3M | 9.23% | 950,000 -25,000 | -3% | -$612K |
|
6
Bio-Rad Laboratories Class A
BIO
$8.06B
| $19.9M | 7.89% | 65,000 +5,000 | +8% | +$1.53M |
|
7
Rigel Pharmaceuticals
RIGL
$697M
| $13.6M | 5.41% | 5,300,000 -200,000 | -4% | -$514K |
|
|
8
Pacira BioSciences
PCRX
$1.2B
| $12.2M | 4.84% | +320,000 | New | +$12.2M |
|
9
AtriCure
ATRC
$1.84B
| $11.4M | 4.52% | 425,000 -175,000 | -29% | -$4.69M |
|
10
Hologic
HOLX
$14.9B
| $10.9M | 4.32% | 225,000 +25,000 | +13% | +$1.21M |
|
|
NVRO
11
DELISTED
NEVRO CORP.
NVRO
| $10M | 3.97% | +160,000 | New | +$10M |
|
|
CORV
12
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $7.58M | 3.01% | 2,400,000 +275,000 | +13% | +$869K |
|
|
13
Alkermes
ALKS
$4.78B
| $5.11M | 2.03% | +140,000 | New | +$5.11M |
|
|
14
Service Corp International
SCI
$11.1B
| $4.82M | 1.91% | 120,000 -155,000 | -56% | -$6.22M |
|
|
ISEE
15
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.23M | 1.68% | 3,000,000 +2,000,000 | +200% | +$2.82M |
|
|
HIND
16
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $2.94M | 1.17% | 2,044,440 -55,560 | -3% | -$80K |
|
17
Thermo Fisher Scientific
TMO
$186B
| $2.74M | 1.09% | +10,000 | New | +$2.74M |
|
|
STRM
18
DELISTED
Streamline Health Solutions
STRM
| $2.05M | 0.81% | 1,950,000 | – | – |
|
|
CMD
19
DELISTED
Cantel Medical Corporation
CMD
| $2.01M | 0.8% | +30,000 | New | +$2.01M |
|
|
VSI
20
DELISTED
Vitamin Shoppe Inc.
VSI
| $93K | 0.04% | 13,158 -586,842 | -98% | -$4.15M |
|
|
21
McKesson
MCK
$85.4B
| – | – | -50,000 | Closed | -$5.52M |
|
|
22
NovoCure
NVCR
$1.38B
| – | – | -670,000 | Closed | -$22.4M |
|
|
OPTN
23
DELISTED
OptiNose
OPTN
| – | – | -300,000 | Closed | -$1.86M |
|
24
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
|
NUVA
25
DELISTED
NuVasive, Inc.
NUVA
| – | – | -500,000 | Closed | -$24.8M |
|